Advancing contrast agents for MRI scans
Magnetic resonance imaging (MRI) scans produce detailed images of the organs and tissues in the body. They can also provide new insights into the biology of cell trafficking and migration. It is important to advance MRI contrast agents in order to render MRI a high-resolution and non-invasive preclinical and clinical imaging modality. The EU-funded SENATOR project will form an international and inter-sectoral network of organisations working on a joint research programme to advance contrast agents based on nanoparticles for perfluorocarbon (19F) MRI. The move towards a new generation of MRI contrast agents has been spurred on by the mounting evidence against gadolinium-based contrast agents (GBCAs). Healthcare professionals have been advised to limit the use of GBCAs to situations in which contrast is deemed absolutely necessary.
Field of science
- /natural sciences/chemical sciences/inorganic chemistry/inorganic compounds
- /medical and health sciences/clinical medicine/radiology/medical imaging/magnetic resonance imaging
Call for proposal
See other projects for this call
Funding SchemeMSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)